FDA watchers warn of 'chaos' inside agency, as regulatory delays, staff hemorrhaging risk America's health (2026-03-04)
Scientific, political pressures colliding at FDA, delaying rare disease treatment for patients who have few or no options, experts said at CNBC Cures Summit.